10x Genomics, Inc. Quarterly Cost of Revenue in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
10x Genomics, Inc. quarterly/annual Cost of Revenue history and growth rate from Q3 2018 to Q3 2024.
  • 10x Genomics, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $45.3M, a 22.1% decline year-over-year.
  • 10x Genomics, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $210M, a 18.2% increase year-over-year.
  • 10x Genomics, Inc. annual Cost of Revenue for 2023 was $209M, a 74% increase from 2022.
  • 10x Genomics, Inc. annual Cost of Revenue for 2022 was $120M, a 62.5% increase from 2021.
  • 10x Genomics, Inc. annual Cost of Revenue for 2021 was $74.1M, a 26.7% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $210M $45.3M -$12.9M -22.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 $223M $48.9M +$1.68M +3.55% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $222M $48.1M +$12.2M +34% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $209M $68.2M +$31.4M +85.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-15
Q3 2023 $178M $58.1M +$27.7M +91.3% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 $150M $47.2M +$19.5M +70.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $131M $35.9M +$10.4M +40.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $120M $36.8M +$9.23M +33.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-15
Q3 2022 $111M $30.4M +$5.86M +23.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $105M $27.7M +$22.8M +464% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-04
Q1 2022 $82.5M $25.5M +$8.42M +49.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $74.1M $27.6M +$8.7M +46% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-15
Q3 2021 $65.4M $24.5M +$10.1M +70.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $55.3M $4.92M -$5.14M -51.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $60.4M $17.1M +$1.95M +12.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $58.5M $18.9M +$2.32M +14% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-16
Q3 2020 $56.2M $14.4M -$1.07M -6.91% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $57.2M $10.1M -$4.95M -33% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $62.2M $15.1M +$1.14M +8.19% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $61M $16.6M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-18
Q3 2019 $15.5M +$10.2M +195% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $15M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $14M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q3 2018 $5.24M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.